Announcement Concerning the Recording of Extraordinary Losses of a U.S. Subsidiary of the Company and of the Suspension of Chloroprene Rubber Production
Results Presentation of FY2024
Notice Concerning Difference Between Full-Year Consolidated Earnings Forecast and Actual Results and Voluntary Return of Part of Executive Compensation
FY2024 Summary of Consolidated Financial Statements
Announcement Concerning Sale of Non-current Assets and Recording of Extraordinary Profit
FY2024 3Q Financial Results Presentation Summary of Q&A Session
Notice Regarding Personnel Changes in Representative Directors and Executive Officers
FY2024 Third Quarter Financial Results Presentation Materials
FY2024 Third Quarter Summary of Consolidated Financial Statements
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.